SCHEMBL28023102

SCHEMBL28023102

CC(=O)Oc1ccc(CCBr)o1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.33
MAPT P10636 4/20 0.33
POLB P06746 3/20 0.33
PTGS2 P35354 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HSD17B10 Q99714 2/20 0.33
ALOX15 P16050 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
LMNA P02545 1/20 0.32
CA12 O43570 3/20 0.32
CA9 Q16790 3/20 0.32
CFD P00746 2/20 0.32
HTT P42858 1/20 0.32
KDM4E B2RXH2 4/20 0.31
PKM P14618 3/20 0.31
GLA P06280 1/20 0.31
GAA P10253 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7499320 0.81 ALDH1A1 (0.49) ALDH1A1MAPTPOLBPTGS2SMN1; SMN2
SCHEMBL27858874 0.80 ALDH1A1 (0.41) ALDH1A1MAPTPOLBPTGS2MEN1
SCHEMBL27472113 0.79 ALDH1A1 (0.35) ALDH1A1MAPTPOLBPTGS2MEN1
SCHEMBL17077645 0.79 CYP2E1 (0.35) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL28057100 0.75 ALDH1A1 (0.40) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL27373829 0.75 PTGS2 (0.38) ALDH1A1MAPTPOLBPTGS2MEN1
SCHEMBL27488370 0.73 HTT (0.42) ALDH1A1MAPTPOLBKMT2ASMN1; SMN2
SCHEMBL27487969 0.72 KMT2A (0.44) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL21662447 0.71 ELANE (0.45) ALDH1A1MAPTPOLBMEN1KMT2A
SCHEMBL6754107 0.70 LMNA (0.43) ALDH1A1MAPTPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104822678-A Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity CHIESI FARMA SPA 2015-08-05 CN disclosed